Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status final results of a phase 2 study (Burkimab)
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Fecha de publicación
2013Título de revista
CANCER
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)